• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终身不吸烟者的肺癌死亡率。

Lung cancer death rates in lifelong nonsmokers.

作者信息

Thun Michael J, Henley S Jane, Burns David, Jemal Ahmedin, Shanks Thomas G, Calle Eugenia E

机构信息

Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA 30229-4251, USA.

出版信息

J Natl Cancer Inst. 2006 May 17;98(10):691-9. doi: 10.1093/jnci/djj187.

DOI:10.1093/jnci/djj187
PMID:16705123
Abstract

BACKGROUND

Few studies have directly measured the age-, sex-, and race-specific risks of lung cancer incidence and mortality among never tobacco smokers. Such data are needed to quantify the risks associated with smoking and to understand racial and sex disparities and temporal trends that are due to factors other than active smoking.

METHODS

We measured age-, sex-, and race-specific rates (per 100,000 person-years at risk) of death from lung cancer among more than 940,000 adults who reported no history of smoking at enrollment in either of two large American Cancer Society Cancer Prevention Study cohorts during 1959-1972 (CPS-I) and 1982-2000 (CPS-II). We compared lung cancer death rates between men and women and between African Americans and whites and analyzed temporal trends in lung cancer death rates among never smokers across the two studies by using directly age-standardized rates as well as Poisson and Cox proportional hazards regression analyses. All statistical tests were two-sided.

RESULTS

The age-standardized lung cancer death rates among never-smoking men and women in CPS-II were 17.1 and 14.7 per 100,000 person-years, respectively. Men who had never smoked had higher age-standardized lung cancer death rates than women in both studies (CPS-I: hazard ratio [HR] = 1.52, 95% confidence interval [CI] = 1.28 to 1.79; CPS-II: HR = 1.21, 95% CI = 1.09 to 1.36). The rate was higher among African American women than white women in CPS-II (HR = 1.43, CI = 1.11 to 1.85). A small temporal increase (CPS-II versus CPS-I) in lung cancer mortality was seen for white women (HR = 1.25, CI = 1.12 to 1.41) and African American women (HR = 1.22, CI = 0.64 to 2.33), but not for white men (HR = 0.89, CI = 0.74 to 1.08). Among white and African American women combined, the temporal increase was statistically significant only among those aged 70-84 years (P < .001).

CONCLUSIONS

Contrary to clinical perception, the lung cancer death rate is not higher in female than in male never smokers and shows little evidence of having increased over time in the absence of smoking. Factors that affect the interpretation of lung cancer trends are discussed. Our novel finding that lung cancer mortality is higher among African American than white women never smokers should be confirmed in other studies.

摘要

背景

很少有研究直接测量从不吸烟者中肺癌发病和死亡的年龄、性别及种族特异性风险。需要此类数据来量化与吸烟相关的风险,并了解由主动吸烟以外的因素导致的种族和性别差异以及时间趋势。

方法

我们测量了超过940,000名成年人中肺癌的年龄、性别及种族特异性死亡率(每100,000人年风险),这些成年人在1959 - 1972年(癌症预防研究I [CPS - I])和1982 - 2000年(癌症预防研究II [CPS - II])这两个美国癌症协会大型队列研究中登记时均无吸烟史。我们比较了男性和女性以及非裔美国人和白人之间的肺癌死亡率,并通过直接年龄标准化率以及泊松和Cox比例风险回归分析,分析了两项研究中从不吸烟者肺癌死亡率的时间趋势。所有统计检验均为双侧检验。

结果

CPS - II中从不吸烟的男性和女性的年龄标准化肺癌死亡率分别为每100,000人年17.1例和14.7例。在两项研究中,从不吸烟的男性的年龄标准化肺癌死亡率均高于女性(CPS - I:风险比[HR] = 1.52,95%置信区间[CI] = 1.28至1.79;CPS - II:HR = 1.21,95% CI = 1.09至1.36)。在CPS - II中,非裔美国女性的肺癌死亡率高于白人女性(HR = 1.43,CI = 1.11至1.85)。白人女性(HR = 1.25,CI = 1.12至1.41)和非裔美国女性(HR = 1.22,CI = 0.64至2.33)的肺癌死亡率有小幅时间上升(CPS - II与CPS - I相比),但白人男性没有(HR = 0.89,CI = 0.74至1.08)。在白人女性和非裔美国女性中,仅70 - 84岁年龄段的时间上升具有统计学意义(P <.001)。

结论

与临床认知相反,从不吸烟女性的肺癌死亡率并不高于从不吸烟男性,且几乎没有证据表明在无吸烟情况下肺癌死亡率随时间增加。讨论了影响肺癌趋势解读的因素。我们的新发现——从不吸烟的非裔美国女性肺癌死亡率高于白人女性——应在其他研究中得到证实。

相似文献

1
Lung cancer death rates in lifelong nonsmokers.终身不吸烟者的肺癌死亡率。
J Natl Cancer Inst. 2006 May 17;98(10):691-9. doi: 10.1093/jnci/djj187.
2
Lung cancer risk among smokers of menthol cigarettes.薄荷醇香烟吸食者的肺癌风险。
J Natl Cancer Inst. 2011 May 18;103(10):810-6. doi: 10.1093/jnci/djr102. Epub 2011 Mar 23.
3
Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies.从不吸烟者肺癌发病情况:13 项队列研究和 22 项癌症登记研究的分析。
PLoS Med. 2008 Sep 30;5(9):e185. doi: 10.1371/journal.pmed.0050185. Epub 2008 Sep 9.
4
Cancer mortality in the United States by education level and race.美国按教育水平和种族划分的癌症死亡率。
J Natl Cancer Inst. 2007 Sep 19;99(18):1384-94. doi: 10.1093/jnci/djm127. Epub 2007 Sep 11.
5
Pancreatic cancer death rates by race among US men and women, 1970-2009.美国男性和女性 1970-2009 年按种族划分的胰腺癌死亡率。
J Natl Cancer Inst. 2013 Nov 20;105(22):1694-700. doi: 10.1093/jnci/djt292. Epub 2013 Nov 7.
6
Lung cancer mortality among never-smokers in the United States: estimating smoking-attributable mortality with nationally representative data.美国从不吸烟者的肺癌死亡率:利用全国代表性数据估计与吸烟有关的死亡率。
Ann Epidemiol. 2020 May;45:5-11. doi: 10.1016/j.annepidem.2020.03.008. Epub 2020 Apr 3.
7
Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001.1993 - 2001年美国按教育程度划分的常见癌症死亡率的长期趋势。
J Natl Cancer Inst. 2008 Jul 16;100(14):1003-12. doi: 10.1093/jnci/djn207. Epub 2008 Jul 8.
8
Recent trends in lung cancer mortality in the United States.美国肺癌死亡率的近期趋势。
J Natl Cancer Inst. 2001 Feb 21;93(4):277-83. doi: 10.1093/jnci/93.4.277.
9
Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.西南肿瘤协作组随机临床试验患者中癌症生存率的种族差异。
J Natl Cancer Inst. 2009 Jul 15;101(14):984-92. doi: 10.1093/jnci/djp175. Epub 2009 Jul 7.
10
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control.《1975 - 2005年美国癌症现状年度报告》,重点关注肺癌、烟草使用及烟草控制的趋势
J Natl Cancer Inst. 2008 Dec 3;100(23):1672-94. doi: 10.1093/jnci/djn389. Epub 2008 Nov 25.

引用本文的文献

1
Disparities in time to treatment initiation of invasive lung cancer among Black and White patients in Tennessee.田纳西州黑人和白人患者在侵袭性肺癌治疗开始时间上的差异。
PLoS One. 2025 Jan 3;20(1):e0311186. doi: 10.1371/journal.pone.0311186. eCollection 2025.
2
Estimated impact of a tobacco-elimination strategy on lung-cancer mortality in 185 countries: a population-based birth-cohort simulation study.185 个国家消除烟草策略对肺癌死亡率的预估影响:基于人口出生队列的模拟研究。
Lancet Public Health. 2024 Oct;9(10):e745-e754. doi: 10.1016/S2468-2667(24)00185-3.
3
Periodontal health status in patients with lung cancer: Case-control study.
肺癌患者的牙周健康状况:病例对照研究。
Int J Health Sci (Qassim). 2024 Jan-Feb;18(1):17-23.
4
A Novel Urine Test Biosensor Platform for Early Lung Cancer Detection.一种用于早期肺癌检测的新型尿液检测生物传感器平台。
Biosensors (Basel). 2023 Jun 6;13(6):627. doi: 10.3390/bios13060627.
5
Opportunities for Achieving the Cancer Moonshot Goal of a 50% Reduction in Cancer Mortality by 2047.实现癌症登月计划目标的机会,即在 2047 年将癌症死亡率降低 50%。
Cancer Discov. 2023 May 4;13(5):1084-1099. doi: 10.1158/2159-8290.CD-23-0208.
6
Incidence of Concomitant Neoplastic Diseases, Tumor Characteristics, and the Survival of Patients with Lung Adenocarcinoma or Squamous Cell Lung Carcinoma in Tobacco Smokers and Non-Smokers-10-Year Retrospective Single-Centre Cohort Study.吸烟者与非吸烟者肺腺癌或肺鳞状细胞癌患者合并肿瘤性疾病的发病率、肿瘤特征及生存情况——一项为期10年的回顾性单中心队列研究
Cancers (Basel). 2023 Mar 22;15(6):1896. doi: 10.3390/cancers15061896.
7
The Role of Electronic Patient-Reported Outcome Measures in Assessing Smoking Status and Cessation for Patients with Lung Cancer.电子患者报告结局指标在评估肺癌患者吸烟状况及戒烟中的作用
Oncol Ther. 2022 Dec;10(2):481-491. doi: 10.1007/s40487-022-00210-7. Epub 2022 Oct 12.
8
Neighborhood disadvantage and lung cancer risk in a national cohort of never smoking Black women.邻里劣势与从不吸烟的黑人女性肺癌风险:一项全国队列研究。
Lung Cancer. 2022 Nov;173:21-27. doi: 10.1016/j.lungcan.2022.08.022. Epub 2022 Sep 8.
9
Evaluation of the Cytotoxicity of Aqueous Extract and Oleo-Essential Oil of Plant Oleo-Gum Resin in Some Human Cancer Cell Lines.植物胶油树脂的水提物和挥发油对几种人癌细胞系的细胞毒性评价。
Anal Cell Pathol (Amst). 2022 Aug 9;2022:9725244. doi: 10.1155/2022/9725244. eCollection 2022.
10
Emergence of Resistance to MTI-101 Selects for a MET Genotype and Phenotype in EGFR Driven PC-9 and PTEN Deleted H446 Lung Cancer Cell Lines.对MTI-101产生耐药性会在EGFR驱动的PC-9和PTEN缺失的H446肺癌细胞系中选择MET基因型和表型。
Cancers (Basel). 2022 Jun 22;14(13):3062. doi: 10.3390/cancers14133062.